Breaking News

AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement

Expands scope of Aji Bio-Pharma's service offerings to include aseptic fill finish services at its San Diego, CA facility.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, entered an expanded manufacturing agreement with AstraZeneca to include drug product manufacturing.   This agreement expands the scope of Aji Bio-Pharma’s service offerings to AstraZeneca to include aseptic fill finish services at its San Diego, CA facility, in addition to small molecule manufacturing services proceeding in Belgium.   “We are excited to expand our manuf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters